Showing results (591-600 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|July 23, 2013
Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor functionMeheroz H Rabadi, Kimberly Kreymborg, Andrea S VincentDrugs in R&D|August 28, 2014
Periodic rosuvastatin or atorvastatin dosing arrays (PRADA): patient-centered practiceTheodore Christou, Hesham R Omar, Roger DimitrovDrugs in R&D|August 21, 2015
Molecular Insight in the Multifunctional Effects of OridoninBrice Ayissi Owona, Herman J SchluesenerDrugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.Drugs in R&D|December 8, 2017
Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl TrisulfideLóránd Kiss, Anna Duke, Kristof Kovacs, et al.Drugs in R&D|December 21, 2017
The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical DataMassimiliano Buoli, Marta Serati, Andrea Botturi, et al.Drugs in R&D|October 24, 2017
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the EvidenceLuisa Costa, Carlo Perricone, Maria Sole Chimenti, et al.Drugs in R&D|September 9, 2020
Nimodipine Pharmacokinetic Variability in Various Patient PopulationsSherif Hanafy Mahmoud, Xinqi Ji, Fadumo Ahmed IsseDrugs in R&D|December 21, 2022
A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic SolutionWilliam J Foster, Andrew L Strahs, Kent W Small, et al.Drugs in R&D|September 22, 2020
Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus ErythematosusChrissy Bolton, Yifan Chen, Rachel Hawthorne, et al.Pageof 89